Mitochondrial Dysfunction in Aged Muscle
Mitochondrial Dysfunction in Aged Muscle
批准号:
7883405
负责人:
David J. Marcinek
金额:
$37.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-10-01 至 2012-06-30
关键词:
AccountingAffectAgeAgingAntioxidantsArtsBiochemicalBiological AssayCell RespirationCell SurvivalComplexCouplingDefectDevelopmentDiagnosisElderlyElectron TransportExerciseFunctional disorderGoalsGrantHealthHumanImpairmentIn VitroIndiumInterventionLeadLinkMagnetic ResonanceMeasurementMeasuresMethodsMitochondriaMusMuscleNatureOpticsOxidative PhosphorylationPathologyPhosphorylationPlayProteinsResearchResearch PersonnelRespiratory ChainRespiratory physiologyRoleSkeletal MuscleSorting - Cell MovementTestingTissuesTrainingTransgenic MiceTransgenic ModelWild Type Mouseage relatedagedbasedisabilityimproved functioningin vivomacromoleculemitochondrial dysfunctionmitochondrial uncoupling protein 3muscle agingoxidationoxidative damageprogramsresearch studysenescencetheoriestooluptake
中文摘要
描述(由申请人提供):线粒体在连接细胞呼吸和细胞生存方面起着关键作用,是许多与年龄相关的退行性病理的关键因素:衰老的线粒体理论认为,氧化损伤会导致不可逆转的线粒体功能障碍和组织随着年龄的增长而退化。在上一次资助周期中开发的新的非侵入性方法显示,在衰老的小鼠和人类骨骼肌中,在体测量的线粒体解偶联至少是部分可逆的。这项建议建立在这些发现的基础上,以评估:1)体内线粒体功能障碍随年龄增长的潜在机制,以及2)线粒体功能障碍各组成部分的可逆性。我们使用最先进的光学和磁共振光谱方法来量化体内线粒体ATP和Oz通量随年龄增长的缺陷。这些缺陷的生化基础是通过对相同小鼠肌肉的体外组织分析确定的。我们研究了不同年龄的野生型小鼠,以评估氧化损伤的积累如何与自然衰老中的线粒体缺陷和功能障碍有关。抗氧化剂活性和解偶联蛋白(UCP3)表达改变的转基因模型被用来确定这种功能障碍的潜在机制。目的1检测氧化损伤和解偶联蛋白活性在野生型和转基因小鼠线粒体偶联(P/O)随增龄丧失中的作用。目的2确定呼吸链缺陷如何损害体内的呼吸功能。我们对野生型和转基因小鼠体内62个通量的测量与不同年龄特定线粒体成分的氧化损伤测量进行了配对。目的3检测AIMS 1和AIMS 2中测量的线粒体缺陷和功能障碍的可逆性。耐力运动用于增加线粒体的增殖和周转,从而取代受损的线粒体,改善功能。这项拟议的研究与人类健康的相关性是双重的。1)确定导致线粒体功能障碍的特定生化机制将确定延缓或逆转随年龄增长的线粒体病变的潜在策略。2)我们的长期目标是开发非侵入性方法来诊断线粒体功能障碍,并跟踪旨在扭转老年人残疾的干预措施的进展。
英文摘要
DESCRIPTION (provided by applicant): Mitochondria play a key role in linking cell respiration to cell survival and are critical elements in many age- related degenerative pathologies: The mitochondrial theory of aging proposes that oxidative damage leads to irreversible mitochondrial dysfunction and tissue degeneration with age. New non-invasive methods developed in the last grant cycle have revealed significant mitochondrial uncoupling measured in vivo in aged mouse and human skeletal muscle that is at least partially reversible. This proposal builds on these findings to evaluate: 1) the mechanisms underlying in vivo mitochondrial dysfunction with age, and 2) the reversibility of each component of mitochondrial dysfunction. We employ state-of-the-art optical and magnetic resonance spectroscopic approaches to quantify in vivo deficits in mitochondrial ATP and Oz fluxes with age. The biochemical bases of these deficits are determined from in vitro tissue analysis of the same mouse muscles. We study wild-type mice over a range of ages to evaluate how accumulation of oxidative damage is related to mitochondrial defects and dysfunction in natural aging. Transgenic models with altered antioxidant activities and uncoupling protein (UCP3) expression are used to identify the underlying mechanisms of this dysfunction. Aim 1 tests the roles of oxidative damage and uncoupling protein activity in the loss of mitochondrial coupling (reduced P/O) with age in wild-type and transgenic mice. Aim 2 determines how respiratory chain defects impair respiratory function in vivo. We pair in vivo measurements of 62 flux with measures of oxidative damage to specific mitochondrial components at multiple ages in wild- type and transgenic mice. Aim 3 tests the reversibility of the mitochondrial defects and dysfunction measured in Aims 1 and 2. Endurance exercise is used to increase mitochondrial proliferation and turnover, thereby replacing damaged mitochondria and improving function. The relevance of the proposed research to human health is two-fold. 1) The determination of the specific biochemical mechanisms leading to mitochondrial dysfunction will identify potential strategies to retard or reverse mitochondrial pathologies with age. 2) Our long-term goal is the development of non- invasive methods to diagnose mitochondrial dysfunction and follow the progress of interventions meant to reverse disability in the elderly.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Redox stress resilience in aging skeletal muscle
-
批准号:10722970
-
项目类别:
-
资助金额:$48.54万
-
财政年份:2023
-
负责人:David J. Marcinek
-
依托单位:
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age
-
批准号:10438785
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2018
-
负责人:David J. Marcinek
-
依托单位:
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age
-
批准号:9702219
-
项目类别:
-
资助金额:$13.02万
-
财政年份:2018
-
负责人:David J. Marcinek
-
依托单位:
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age
-
批准号:10205069
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2018
-
负责人:David J. Marcinek
-
依托单位:
Preventing Skeletal and Cardiac Muscle Aging by Restoring Mitochondrial Function
-
批准号:9564597
-
项目类别:
-
资助金额:$81.95万
-
财政年份:2017
-
负责人:David J. Marcinek
-
依托单位:
SS peptides: a new approach to improve mitochondrial and skeletal muscle function
-
批准号:8444893
-
项目类别:
-
资助金额:$26.75万
-
财政年份:2012
-
负责人:David J. Marcinek
-
依托单位:
SS peptides: improve mitochondrial and skeletal muscle function with age
-
批准号:8554758
-
项目类别:
-
资助金额:$21.29万
-
财政年份:2012
-
负责人:David J. Marcinek
-
依托单位:
Mitochondrial fuction, oxidative damage, and aging
-
批准号:7022219
-
项目类别:
-
资助金额:$10.26万
-
财政年份:2005
-
负责人:David J. Marcinek
-
依托单位:
Mitochondrial function, oxidative damage, and aging
-
批准号:7198108
-
项目类别:
-
资助金额:$10.26万
-
财政年份:2005
-
负责人:David J. Marcinek
-
依托单位:
Mitochondrial function, oxidative damage, and aging
-
批准号:6870808
-
项目类别:
-
资助金额:$10.26万
-
财政年份:2005
-
负责人:David J. Marcinek
-
依托单位:
Mitochondrial function, oxidative damage, and aging
-
批准号:7369717
-
项目类别:
-
资助金额:$10.26万
-
财政年份:2005
-
负责人:David J. Marcinek
-
依托单位:
Mitochondrial function, oxidative damage, and aging
-
批准号:7575639
-
项目类别:
-
资助金额:$10.26万
-
财政年份:2005
-
负责人:David J. Marcinek
-
依托单位:
Nathan Shock Center of Excellence in Basic Biology of Aging
-
批准号:10670087
-
项目类别:
-
资助金额:$96.2万
-
财政年份:1997
-
负责人:David J. Marcinek
-
依托单位:
Mitochondrial Dysfunction in Aged Muscle
-
批准号:7642396
-
项目类别:
-
资助金额:$38.34万
-
财政年份:1988
-
负责人:David J. Marcinek
-
依托单位:
Mitochondrial-targeted Antioxidants, Aging and AZT in Skeletal Muscle Dysfunction
-
批准号:8046002
-
项目类别:
-
资助金额:$30.28万
-
财政年份:--
-
负责人:David J. Marcinek
-
依托单位:
Project 2: Mitochondrial ROS in aging-related skeletal muscle aging
-
批准号:9918233
-
项目类别:
-
资助金额:$29.97万
-
财政年份:--
-
负责人:David J. Marcinek
-
依托单位:
海外基金